Accelerate Diagnostics Stock Price, News & Analysis (NASDAQ:AXDX)

$28.75 -0.40 (-1.37 %)
(As of 12/12/2017 04:00 PM ET)
Previous Close$29.15
Today's Range$28.55 - $29.45
52-Week Range$16.75 - $30.45
Volume402,900 shs
Average Volume361,290 shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.17

About Accelerate Diagnostics (NASDAQ:AXDX)

Accelerate Diagnostics logoAccelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.

Receive AXDX News and Ratings via Email

Sign-up to receive the latest news and ratings for AXDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AXDX
CUSIPN/A
Phone520-365-3100

Debt

Debt-to-Equity RatioN/A
Current Ratio21.24%
Quick Ratio20.06%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$250,000.00
Price / Sales6,371.00
Cash FlowN/A
Price / CashN/A
Book Value$1.51 per share
Price / Book19.04

Profitability

Trailing EPS($1.20)
Net Income$-66,370,000.00
Net Margins-3,085.36%
Return on Equity-60.99%
Return on Assets-57.85%

Miscellaneous

EmployeesN/A
Outstanding Shares55,400,000

Accelerate Diagnostics (NASDAQ:AXDX) Frequently Asked Questions

What is Accelerate Diagnostics' stock symbol?

Accelerate Diagnostics trades on the NASDAQ under the ticker symbol "AXDX."

How were Accelerate Diagnostics' earnings last quarter?

Accelerate Diagnostics Inc (NASDAQ:AXDX) released its quarterly earnings data on Friday, May, 5th. The medical research company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.34) by $0.07. The medical research company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.60 million. Accelerate Diagnostics had a negative return on equity of 60.99% and a negative net margin of 3,085.36%. View Accelerate Diagnostics' Earnings History.

Where is Accelerate Diagnostics' stock going? Where will Accelerate Diagnostics' stock price be in 2017?

2 brokerages have issued 12-month price targets for Accelerate Diagnostics' shares. Their forecasts range from $32.00 to $34.00. On average, they anticipate Accelerate Diagnostics' stock price to reach $33.00 in the next year. View Analyst Ratings for Accelerate Diagnostics.

Who are some of Accelerate Diagnostics' key competitors?

Who are Accelerate Diagnostics' key executives?

Accelerate Diagnostics' management team includes the folowing people:

  • John Patience, Independent Chairman of the Board (Age 69)
  • Lawrence Mehren, President, Chief Executive Officer, Director (Age 50)
  • Steve Reichling, Chief Financial Officer (Age 38)
  • Joan Martin, Executive Vice President & Head of Europe, Middle East, and Africa (Age 48)
  • Ron Price, Senior Vice President and Head of Commercial Operations, Americas (Age 53)
  • Charles Watts, Director
  • Tom Brown, Independent Director (Age 68)
  • Mark C. Miller, Independent Director (Age 61)
  • Jack W. Schuler, Independent Director (Age 76)
  • Matthew W. Strobeck Ph.D., Independent Director (Age 44)

Who owns Accelerate Diagnostics stock?

Accelerate Diagnostics' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Kornitzer Capital Management Inc. KS (0.96%), AXA (0.78%), Bank of New York Mellon Corp (0.23%), Schwab Charles Investment Management Inc. (0.22%), Strs Ohio (0.19%) and Artemis Investment Management LLP (0.18%). Company insiders that own Accelerate Diagnostics stock include Jack W Schuler, Lawrence Mehren, Matthew Strobeck and Steven Reichling. View Institutional Ownership Trends for Accelerate Diagnostics.

Who sold Accelerate Diagnostics stock? Who is selling Accelerate Diagnostics stock?

Accelerate Diagnostics' stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, New York State Common Retirement Fund, Essex Investment Management Co. LLC, L & S Advisors Inc, Wells Fargo & Company MN and California State Teachers Retirement System. Company insiders that have sold Accelerate Diagnostics company stock in the last year include Lawrence Mehren and Steven Reichling. View Insider Buying and Selling for Accelerate Diagnostics.

Who bought Accelerate Diagnostics stock? Who is buying Accelerate Diagnostics stock?

Accelerate Diagnostics' stock was purchased by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS, AXA, Strs Ohio, Artemis Investment Management LLP, Jane Street Group LLC, Commonwealth of Pennsylvania Public School Empls Retrmt SYS, GSA Capital Partners LLP and First Trust Advisors LP. Company insiders that have bought Accelerate Diagnostics stock in the last two years include Jack W Schuler and Matthew Strobeck. View Insider Buying and Selling for Accelerate Diagnostics.

How do I buy Accelerate Diagnostics stock?

Shares of Accelerate Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Accelerate Diagnostics' stock price today?

One share of Accelerate Diagnostics stock can currently be purchased for approximately $28.75.

How big of a company is Accelerate Diagnostics?

Accelerate Diagnostics has a market capitalization of $1.61 billion and generates $250,000.00 in revenue each year. The medical research company earns $-66,370,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis.

How can I contact Accelerate Diagnostics?

Accelerate Diagnostics' mailing address is 3950 South Country Club Suite 470, Tucson AZ, 85714. The medical research company can be reached via phone at 520-365-3100 or via email at [email protected]


MarketBeat Community Rating for Accelerate Diagnostics (AXDX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  101 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Accelerate Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Accelerate Diagnostics (NASDAQ:AXDX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.33$30.33$30.33$30.33
Price Target Upside: 8.14% upside8.14% upside8.14% upside7.18% upside

Accelerate Diagnostics (NASDAQ:AXDX) Consensus Price Target History

Price Target History for Accelerate Diagnostics (NASDAQ:AXDX)

Accelerate Diagnostics (NASDAQ:AXDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2017BTIG ResearchReiterated RatingBuy -> Buy$34.00HighView Rating Details
6/5/2017Piper Jaffray CompaniesReiterated RatingOverweight$30.00 -> $32.00LowView Rating Details
8/9/2016J P Morgan Chase & CoBoost Price TargetOverweight$17.00 -> $25.00N/AView Rating Details
1/29/2016William BlairReiterated RatingBuyN/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

Accelerate Diagnostics (NASDAQ:AXDX) Earnings History and Estimates Chart

Earnings by Quarter for Accelerate Diagnostics (NASDAQ:AXDX)

Accelerate Diagnostics (NASDAQ AXDX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017Q2 2017($0.30)($0.31)$1.40 million$0.70 millionViewListenView Earnings Details
5/5/2017Q1($0.34)($0.27)$0.60 million$0.50 millionViewListenView Earnings Details
2/27/2017Q4 2016($0.35)($0.31)$0.24 million$0.04 millionViewListenView Earnings Details
11/9/2016Q3 2016($0.35)($0.34)$0.02 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Accelerate Diagnostics (NASDAQ:AXDX) Earnings Estimates

2017 EPS Consensus Estimate: ($1.29)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.34)($0.34)($0.34)
Q2 20171($0.34)($0.34)($0.34)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.30)($0.30)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Accelerate Diagnostics (NASDAQ:AXDX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Accelerate Diagnostics (NASDAQ AXDX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 50.00%
Institutional Ownership Percentage: 47.98%
Insider Trades by Quarter for Accelerate Diagnostics (NASDAQ:AXDX)
Institutional Ownership by Quarter for Accelerate Diagnostics (NASDAQ:AXDX)

Accelerate Diagnostics (NASDAQ AXDX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/17/2017Jack W SchulerDirectorBuy5,500$22.00$121,000.00View SEC Filing  
11/15/2017Jack W SchulerDirectorBuy20,000$20.00$400,000.00View SEC Filing  
11/13/2017Jack W SchulerDirectorBuy20,000$18.98$379,600.00View SEC Filing  
11/10/2017Jack W SchulerDirectorBuy51,181$18.67$955,549.27View SEC Filing  
11/8/2017Jack W SchulerDirectorBuy50,000$18.46$923,000.00View SEC Filing  
11/6/2017Jack W SchulerDirectorBuy340,964$18.51$6,311,243.64View SEC Filing  
10/18/2017Jack W SchulerDirectorBuy45,000$20.14$906,300.00View SEC Filing  
10/16/2017Jack W SchulerDirectorBuy59,922$20.07$1,202,634.54View SEC Filing  
10/13/2017Jack W SchulerDirectorBuy61,300$19.29$1,182,477.00View SEC Filing  
10/12/2017Jack W SchulerDirectorBuy276,200$19.74$5,452,188.00View SEC Filing  
10/11/2017Jack W SchulerDirectorBuy51,600$20.27$1,045,932.00View SEC Filing  
8/21/2017Jack W SchulerDirectorBuy50,000$21.45$1,072,500.00View SEC Filing  
8/17/2017Lawrence MehrenInsiderSell223,215$22.40$5,000,016.00View SEC Filing  
8/15/2017Jack W SchulerDirectorBuy8,200$21.35$175,070.00View SEC Filing  
8/14/2017Jack W SchulerDirectorBuy23,400$21.35$499,590.00View SEC Filing  
8/11/2017Jack W SchulerDirectorBuy80,000$21.43$1,714,400.00View SEC Filing  
6/21/2017Steven ReichlingInsiderSell30,000$28.90$867,000.00View SEC Filing  
1/9/2017Lawrence MehrenInsiderSell400,068$19.00$7,601,292.00View SEC Filing  
1/9/2017Matthew StrobeckDirectorBuy8,000$19.00$152,000.00View SEC Filing  
6/30/2016Jack W SchulerDirectorBuy90,147$13.95$1,257,550.65View SEC Filing  
6/14/2016Jack W SchulerDirectorBuy14,033$13.67$191,831.11View SEC Filing  
6/13/2016Jack W SchulerDirectorBuy15,967$13.70$218,747.90View SEC Filing  
6/10/2016Jack W SchulerDirectorBuy88,316$14.69$1,297,362.04View SEC Filing  
6/9/2016Jack W SchulerDirectorBuy101,272$14.14$1,431,986.08View SEC Filing  
5/20/2016Jack W SchulerDirectorBuy4,270$11.04$47,140.80View SEC Filing  
5/17/2016Jack W SchulerDirectorBuy10,000$11.45$114,500.00View SEC Filing  
5/16/2016Jack W SchulerDirectorBuy11,511$11.91$137,096.01View SEC Filing  
5/13/2016Jack W SchulerDirectorBuy20,000$12.45$249,000.00View SEC Filing  
2/9/2016Jack W SchulerDirectorBuy600,000$11.86$7,116,000.00View SEC Filing  
2/8/2016Jack W SchulerDirectorBuy20,000$12.32$246,400.00View SEC Filing  
2/5/2016Jack W SchulerDirectorBuy7,308$12.65$92,446.20View SEC Filing  
2/4/2016Jack W SchulerDirectorBuy10,000$12.98$129,800.00View SEC Filing  
2/3/2016Jack W SchulerDirectorBuy50,100$13.09$655,809.00View SEC Filing  
2/2/2016Jack W SchulerDirectorBuy20,000$13.46$269,200.00View SEC Filing  
1/21/2016Jack W SchulerDirectorBuy10,000$15.02$150,200.00View SEC Filing  
12/10/2015Larry N FeinbergMajor ShareholderBuy117,647$17.00$1,999,999.00View SEC Filing  
11/5/2015Jack W SchulerDirectorBuy11,899$16.81$200,022.19View SEC Filing  
11/4/2015Jack W SchulerDirectorBuy52,837$16.81$888,189.97View SEC Filing  
10/22/2015Jack W SchulerDirectorBuy2,160$15.82$34,171.20View SEC Filing  
9/29/2015Brink Frank Jm TenDirectorBuy9,800$15.24$149,352.00View SEC Filing  
8/26/2015Jack W SchulerDirectorBuy10,000$17.81$178,100.00View SEC Filing  
8/25/2015Jack W SchulerDirectorBuy10,000$18.56$185,600.00View SEC Filing  
4/17/2015Jack W SchulerDirectorBuy11,000$21.94$241,340.00View SEC Filing  
3/19/2015Matthew StrobeckDirectorBuy2,000$22.04$44,080.00View SEC Filing  
3/9/2015Jack W SchulerDirectorBuy22,584$17.18$387,993.12View SEC Filing  
1/5/2015Jack W SchulerDirectorBuy18,000$18.93$340,740.00View SEC Filing  
9/22/2014Jack W SchulerDirectorBuy2,588$16.44$42,546.72View SEC Filing  
9/19/2014Jack W SchulerDirectorBuy32,411$16.67$540,291.37View SEC Filing  
8/21/2014Jack W SchulerDirectorBuy2,900$16.79$48,691.00View SEC Filing  
8/5/2014Larry N FeinbergMajor ShareholderBuy11,835$15.92$188,413.20View SEC Filing  
8/5/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  
8/4/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  
7/16/2014Larry N FeinbergMajor ShareholderBuy20,000$21.54$430,800.00View SEC Filing  
7/1/2014Jack W SchulerDirectorBuy8,698$25.70$223,538.60View SEC Filing  
6/30/2014Jack W SchulerDirectorBuy10,000$26.09$260,900.00View SEC Filing  
6/30/2014Larry N FeinbergMajor ShareholderBuy20,000$25.72$514,400.00View SEC Filing  
5/12/2014Larry N FeinbergMajor ShareholderBuy297,618$16.80$4,999,982.40View SEC Filing  
2/5/2014Larry N FeinbergMajor ShareholderBuy8,554$24.78$211,968.12View SEC Filing  
1/27/2014Larry N FeinbergMajor ShareholderBuy16,307$13.09$213,458.63View SEC Filing  
12/31/2013Larry N FeinbergMajor ShareholderBuy84,081$12.29$1,033,355.49View SEC Filing  
10/30/2013Larry N FeinbergMajor ShareholderBuy10,000$12.95$129,500.00View SEC Filing  
8/30/2013Larry N FeinbergMajor ShareholderBuy16,001$9.76$156,169.76View SEC Filing  
8/28/2013Larry N FeinbergMajor ShareholderBuy158,445$9.80$1,552,761.00View SEC Filing  
8/16/2013Jack W SchulerDirectorBuy78,494$7.88$618,532.72View SEC Filing  
8/14/2013Jack W SchulerDirectorBuy413,090$8.04$3,321,243.60View SEC Filing  
8/14/2013Larry N FeinbergMajor ShareholderBuy36,814$7.24$266,533.36View SEC Filing  
8/9/2013Larry N FeinbergMajor ShareholderBuy35,168$7.30$256,726.40View SEC Filing  
6/21/2013Larry N FeinbergMajor ShareholderBuy114,250$8.00$914,000.00View SEC Filing  
6/12/2013Larry N FeinbergMajor ShareholderBuy7,175$8.41$60,341.75View SEC Filing  
6/7/2013Larry N FeinbergMajor ShareholderBuy45,508$8.33$379,081.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Accelerate Diagnostics (NASDAQ AXDX) News Headlines

Source:
DateHeadline
ETFs with exposure to Accelerate Diagnostics, Inc. : December 12, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : December 12, 2017
finance.yahoo.com - December 12 at 3:28 PM
Accelerate Diagnostics Hits 80-Plus Relative Strength Rating BenchmarkAccelerate Diagnostics Hits 80-Plus Relative Strength Rating Benchmark
finance.yahoo.com - December 8 at 3:28 PM
Zacks: Analysts Set $26.50 Target Price for Accelerate Diagnostics Inc (AXDX)Zacks: Analysts Set $26.50 Target Price for Accelerate Diagnostics Inc (AXDX)
www.americanbankingnews.com - December 6 at 5:30 PM
Stocks With Rising Relative Strength: Accelerate DiagnosticsStocks With Rising Relative Strength: Accelerate Diagnostics
finance.yahoo.com - December 6 at 3:28 PM
Accelerate Diagnostics Meets 80-Plus Relative Strength Rating BenchmarkAccelerate Diagnostics Meets 80-Plus Relative Strength Rating Benchmark
finance.yahoo.com - December 1 at 3:32 PM
ETFs with exposure to Accelerate Diagnostics, Inc. : November 30, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 3:28 PM
First Week Of January 2018 Options Trading For Accelerate Diagnostics (AXDX)First Week Of January 2018 Options Trading For Accelerate Diagnostics (AXDX)
www.thestreet.com - November 21 at 4:49 PM
Zacks: Brokerages Set $29.50 Target Price for Accelerate Diagnostics, Inc. (AXDX)Zacks: Brokerages Set $29.50 Target Price for Accelerate Diagnostics, Inc. (AXDX)
www.americanbankingnews.com - November 21 at 3:16 PM
ETFs with exposure to Accelerate Diagnostics, Inc. : November 20, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 5:32 PM
Accelerate Diagnostics, Inc. (AXDX) Director Buys $121,000.00 in StockAccelerate Diagnostics, Inc. (AXDX) Director Buys $121,000.00 in Stock
www.americanbankingnews.com - November 20 at 4:43 PM
Accelerate Diagnostics (AXDX) Appoints Dr. Charles Watts to BoardAccelerate Diagnostics (AXDX) Appoints Dr. Charles Watts to Board
www.streetinsider.com - November 17 at 3:59 PM
Accelerate Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : AXDX-US : November 17, 2017Accelerate Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : AXDX-US : November 17, 2017
finance.yahoo.com - November 17 at 9:54 AM
Insider Buying: Accelerate Diagnostics, Inc. (AXDX) Director Acquires 20,000 Shares of StockInsider Buying: Accelerate Diagnostics, Inc. (AXDX) Director Acquires 20,000 Shares of Stock
www.americanbankingnews.com - November 16 at 4:48 PM
Accelerate Diagnostics (AXDX) Appoints Dr. Charles Watts to Board - StreetInsider.comAccelerate Diagnostics (AXDX) Appoints Dr. Charles Watts to Board - StreetInsider.com
www.streetinsider.com - November 16 at 4:35 PM
Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of DirectorsAccelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
finance.yahoo.com - November 16 at 4:35 PM
Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York CityAccelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City
finance.yahoo.com - November 16 at 11:44 AM
Accelerate Diagnostics (AXDX) in Focus: Stock Moves 6.7% HigherAccelerate Diagnostics (AXDX) in Focus: Stock Moves 6.7% Higher
finance.yahoo.com - November 16 at 11:44 AM
Accelerate Diagnostics, Inc. (AXDX) Director Buys $379,600.00 in StockAccelerate Diagnostics, Inc. (AXDX) Director Buys $379,600.00 in Stock
www.americanbankingnews.com - November 15 at 8:22 PM
Accelerate Diagnostics, Inc. (AXDX) Director Buys $955,549.27 in StockAccelerate Diagnostics, Inc. (AXDX) Director Buys $955,549.27 in Stock
www.americanbankingnews.com - November 14 at 4:32 PM
Insider Buying: Accelerate Diagnostics, Inc. (AXDX) Director Buys 50,000 Shares of StockInsider Buying: Accelerate Diagnostics, Inc. (AXDX) Director Buys 50,000 Shares of Stock
www.americanbankingnews.com - November 13 at 4:21 PM
ETFs with exposure to Accelerate Diagnostics, Inc. : November 9, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : November 9, 2017
finance.yahoo.com - November 9 at 5:29 PM
Accelerate Diagnostics, Inc. :AXDX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017Accelerate Diagnostics, Inc. :AXDX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017
finance.yahoo.com - November 8 at 6:39 PM
Accelerate Diagnostics, Inc. (AXDX) Director Jack W. Schuler Buys 340,964 SharesAccelerate Diagnostics, Inc. (AXDX) Director Jack W. Schuler Buys 340,964 Shares
www.americanbankingnews.com - November 8 at 3:30 PM
Should You Buy Accelerate Diagnostics Inc (AXDX)?Should You Buy Accelerate Diagnostics Inc (AXDX)?
finance.yahoo.com - November 7 at 6:16 PM
Zacks Investment Research Lowers Accelerate Diagnostics, Inc. (AXDX) to SellZacks Investment Research Lowers Accelerate Diagnostics, Inc. (AXDX) to Sell
www.americanbankingnews.com - November 7 at 5:44 PM
Accelerate Diagnostics (AXDX) CEO Lawrence Mehren on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaAccelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 5 at 9:12 PM
Brokerages Expect Accelerate Diagnostics, Inc. (AXDX) to Post ($0.31) EPSBrokerages Expect Accelerate Diagnostics, Inc. (AXDX) to Post ($0.31) EPS
www.americanbankingnews.com - November 5 at 3:48 AM
Edited Transcript of AXDX earnings conference call or presentation 2-Nov-17 8:15pm GMTEdited Transcript of AXDX earnings conference call or presentation 2-Nov-17 8:15pm GMT
finance.yahoo.com - November 3 at 4:44 PM
Accelerate Diagnostics reports 3Q lossAccelerate Diagnostics reports 3Q loss
finance.yahoo.com - November 2 at 9:57 PM
Accelerate Diagnostics, Inc. to Host Earnings CallAccelerate Diagnostics, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 4:52 PM
Accelerate Diagnostics reports Q3 2017 financial resultsAccelerate Diagnostics reports Q3 2017 financial results
finance.yahoo.com - November 2 at 4:52 PM
Accelerate Diagnostics, Inc. (AXDX) Set to Announce Earnings on TuesdayAccelerate Diagnostics, Inc. (AXDX) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - October 31 at 7:44 AM
ETFs with exposure to Accelerate Diagnostics, Inc. : October 26, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : October 26, 2017
finance.yahoo.com - October 26 at 4:19 PM
Noteworthy Friday Option Activity: AXDX, CLF, MANNoteworthy Friday Option Activity: AXDX, CLF, MAN
www.nasdaq.com - October 20 at 6:05 PM
Accelerate Diagnostics, Inc. (AXDX) Director Purchases 45,000 SharesAccelerate Diagnostics, Inc. (AXDX) Director Purchases 45,000 Shares
www.americanbankingnews.com - October 20 at 4:22 PM
Jack W. Schuler Acquires 59,922 Shares of Accelerate Diagnostics, Inc. (AXDX) StockJack W. Schuler Acquires 59,922 Shares of Accelerate Diagnostics, Inc. (AXDX) Stock
www.americanbankingnews.com - October 18 at 4:20 PM
Insider Buying: Accelerate Diagnostics, Inc. (AXDX) Director Acquires 61,300 Shares of StockInsider Buying: Accelerate Diagnostics, Inc. (AXDX) Director Acquires 61,300 Shares of Stock
www.americanbankingnews.com - October 17 at 4:22 PM
Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd - GlobeNewswire (press release)Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd - GlobeNewswire (press release)
globenewswire.com - October 16 at 10:08 PM
ETFs with exposure to Accelerate Diagnostics, Inc. : October 16, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : October 16, 2017
finance.yahoo.com - October 16 at 5:03 PM
Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2ndAccelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd
finance.yahoo.com - October 16 at 5:03 PM
Accelerate Diagnostics, Inc. (AXDX) Director Purchases $5,452,188.00 in StockAccelerate Diagnostics, Inc. (AXDX) Director Purchases $5,452,188.00 in Stock
www.americanbankingnews.com - October 16 at 4:32 PM
Accelerate Diagnostics, Inc. (AXDX) Director Buys $1,045,932.00 in StockAccelerate Diagnostics, Inc. (AXDX) Director Buys $1,045,932.00 in Stock
www.americanbankingnews.com - October 13 at 1:34 PM
Accelerate Diagnostics Stock Sees Short Interest Decline 13.2%Accelerate Diagnostics Stock Sees Short Interest Decline 13.2%
www.thestreet.com - October 11 at 5:47 PM
ETFs with exposure to Accelerate Diagnostics, Inc. : October 5, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : October 5, 2017
finance.yahoo.com - October 5 at 2:19 PM
Accelerate Diagnostics (AXDX) and Its Competitors Financial ContrastAccelerate Diagnostics (AXDX) and Its Competitors Financial Contrast
www.americanbankingnews.com - September 20 at 2:08 AM
ETFs with exposure to Accelerate Diagnostics, Inc. : September 19, 2017ETFs with exposure to Accelerate Diagnostics, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 9:17 PM
Financial Contrast: Accelerate Diagnostics (AXDX) and Viveve Medical (VIVE)Financial Contrast: Accelerate Diagnostics (AXDX) and Viveve Medical (VIVE)
www.americanbankingnews.com - September 19 at 4:26 PM
Plaintiffs Dismiss Class Action Appeal Against Accelerate Diagnostics - GlobeNewswire (press release)Plaintiffs Dismiss Class Action Appeal Against Accelerate Diagnostics - GlobeNewswire (press release)
globenewswire.com - September 13 at 5:25 PM
Plaintiffs Dismiss Class Action Appeal Against Accelerate DiagnosticsPlaintiffs Dismiss Class Action Appeal Against Accelerate Diagnostics
feeds.benzinga.com - September 13 at 1:37 PM
Boston Scientific Corporation (BSX) & Accelerate Diagnostics (AXDX) Head to Head AnalysisBoston Scientific Corporation (BSX) & Accelerate Diagnostics (AXDX) Head to Head Analysis
www.americanbankingnews.com - September 11 at 6:26 PM

SEC Filings

Accelerate Diagnostics (NASDAQ:AXDX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Accelerate Diagnostics (NASDAQ:AXDX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Accelerate Diagnostics (NASDAQ AXDX) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.